TickerFactsScreenerDevelopers

Processa Pharmaceuticals, Inc. (PCSA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: $2.56M2013: $1.67M2014: $1.21M2015: -$85.7K2016: -$2.27M2017: $373.2K2018: $9.70M2019: $8.01M2020: $22.94M2021: $25.49M2022: $7.47M2023: $4.99M2024: $1.70M2025: $5.58M$5.58M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$5.58M+228.8%
2024$1.70M-66.0%
2023$4.99M-33.2%
2022$7.47M-70.7%
2021$25.49M+11.1%
2020$22.94M+186.3%
2019$8.01M-17.4%
2018$9.70M+2499.7%
2017$373.2K+116.5%
2016-$2.27M-2545.4%
2015-$85.7K-107.1%
2014$1.21M-27.7%
2013$1.67M-34.8%
2012$2.56M—